Dry Eye Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future grow ...

Routine evaluation of meibomian glands, starting in childhood, is crucial for identifying and managing this progressive ...

Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...

A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...

Researchers at the University of Wisconsin are testing a groundbreaking cell therapy for Sjögren’s disease, a complex ...

Incomplete blinking is associated with meibomian gland dropout, meibum quality, and lipid layer thickness, and may predict DED.

Thermal pulsation therapy delivered after cataract surgery can help address postoperative dry eye disease symptoms.

A look at the biggest news and advancements in ophthalmology in 2024.

The exact cause of Alzheimer's disease hasn't been identified. The current thinking is that it develops due to a combination of genetic, lifestyle, and environmental risk factors.1 The brains of ...

The company’s pipeline products include TP-03, TP-04 and TP-05. Its pipeline treats meibomian gland disease, rosacea disease, lyme disease and malaria. Tarsus Pharmaceuticals also carries out Xdemvy ...

Lung diseases are some of the most common medical conditions in the world. Tens of millions of people have lung disease in the U.S. alone. Smoking, infections, and genes cause most lung diseases.